RE:RE:RE:RE:RE:Prometic type C meeting with FDA about CMC Changes My guess is that once the Type C meeting on CMC plan takes place we will have a new stock issue announced.
Only the plans for CMC quality control will have been "agreed to". I think, though I do not know for sure, the changes will not have been implemented. And as we all know, agreement from the FDA is only permission to proceed.
Where is the partnership we have been hearing about for years?
Wendel might manage it. But, It could be a whole lot harder to do if the big boss's reputation is in doubt. Right now, it seems to me, PLI's reputation rests entirely on the science team. I have my own doubt abouts the CEO and the CFO but I have no information.
We are looking at a big dilution if PLI plans to continue on all research fronts. Also a reverse split might happen but not for the previously stated reason to get on the Nasdaq. The reverse will be to taise more cash now.
High Tea is right about a cash problem.. Its why we are sub 60 cents. Management is allowing uncertainty to dominate the public perception of the viability of the company. We are being fcked over.